IP 203 WHITE PILL – IDENTIFICATION, DOSAGE, SIDE EFFECTS

A white pill imprinted with IP 203 is a generic prescription formulation of Oxycodone Hydrochloride 5 mg and Acetaminophen 325 mg. Commonly recognized under brand names such as Percocet, Endocet, or Roxicet, this combination medication unites a semi-synthetic opioid with a non-opioid analgesic.

Because it contains oxycodone, it is classified as a Schedule II (C-II) controlled substance in the United States due to its high potential for abuse, physical dependence, and addiction.

Pill Identification & Brand Details

Characteristic Specification

• Brand Equivalent – Percocet (5 mg / 325 mg), Endocet, Roxicet
• Active Ingredients – Oxycodone Hydrochloride (5 mg) + Acetaminophen (325 mg)
• Imprint Code – IP on one side, 203 on the other side
• Drug Class – Opioid Analgesic / Non-Opioid Analgesic Combination
• Color & Shape – White to off-white, Round or Capsule-shaped
• Primary Manufacturer – Amneal Pharmaceuticals
• Controlled Substance Class – Schedule II (C-II)

• Note: Always confirm unidentified or loose medications with a licensed pharmacist before taking them. Counterfeit illicit tablets mimicking this exact imprint are common on the black market and can contain lethal amounts of illicit fentanyl.

Indications & Medical Uses

Oxycodone and acetaminophen combination tablets are indicated for the management of acute, severe pain that is significant enough to require an opioid analgesic and for which alternative treatments (such as non-opioid medications) are inadequate or tolerated poorly:

• Post-Surgical Pain: Relief following orthopedic, general, or dental surgery.
• Acute Traumatic Pain: Management of pain resulting from severe injuries, fractures, or major trauma.
• Short-Term Acute Medical Conditions: Severe breakthrough pain associated with acute tissue injury.

• Note: Because of the risks of addiction, abuse, and misuse, it is generally not recommended for long-term chronic pain unless prescribed under strict pain management supervision.

Mechanism of Action

This combination medication provides dual-action analgesia by attacking pain pathways in both the central and peripheral nervous systems:

Oxycodone Hydrochloride (5 mg)

• Mu-Opioid Receptor Agonism: Oxycodone is a semi-synthetic opioid derived from the opium alkaloid thebaine. It acts as a pure agonist at the opioid (mu-opioid) receptors in the central nervous system (CNS).
• Pain Signal Interruption: Binding to these receptors inhibits the release of nociceptive neurotransmitters (such as Substance P and glutamate) in the spinal cord, altering the perception of and emotional response to pain.

Acetaminophen (325 mg)

• Central Prostaglandin Inhibition: Acetaminophen acts primarily in the brain to inhibit cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis in the CNS.
• Synergistic Analgesia: By reducing peripheral pain perception and elevating the central pain threshold through non-opioid mechanisms, acetaminophen works synergistically with oxycodone, allowing lower doses of the opioid component to achieve effective pain relief.

Dosage & Administration

Dosage should be titrated to the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

• Standard Adult Dosing:
• 1 to 2 tablets taken orally every 6 hours as needed for pain.
• The maximum single dose is typically 2 tablets (10 mg oxycodone / 650 mg acetaminophen).

• Maximum Daily Limits:
• Acetaminophen Limit: Total daily acetaminophen intake from all sources (including OTC cold/pain remedies) should not exceed 4,000 mg per 24 hours (and often capped at 3,000 mg for added safety) to prevent severe liver damage.
• Oxycodone Limit: Determined by the prescribing physician based on opioid tolerance.

• Administration Rules:
• Swallow tablets whole with water. Do not crush, chew, or dissolve them.
• Can be taken with or without food; taking it with food or milk can help reduce mild nausea.

Side Effects

Common Side Effects

• Central Nervous System: Drowsiness, sedation, dizziness, lightheadedness, or headache.
• Gastrointestinal: Nausea, vomiting, abdominal pain, and severe constipation (opioid-induced constipation does not lessen over time and often requires stool softeners).
• Dermatologic: Itching (pruritus), flushing, or sweating.

Severe Adverse Reactions (Seek Immediate Emergency Care)

• Severe Respiratory Depression: Dangerously slow, shallow, or labored breathing, extreme drowsiness, or inability to wake up.
• Opioid Overdose Triad: Pinpoint pupils, unconsciousness/coma, and respiratory depression.
• Hepatotoxicity / Liver Failure: Jaundice (yellowing of skin/eyes), dark urine, upper right abdominal pain, or extreme lethargy.
• Adrenal Insufficiency: Severe fatigue, weakness, dizziness, nausea, and vomiting after prolonged opioid use.
• Serotonin Syndrome: Agitation, hallucinations, rapid heart rate, muscle stiffness, or fever when combined with serotonergic medications.

Precautions & Drug Interactions

• CNS Depressants & Alcohol: Combining oxycodone with alcohol, benzodiazepines (e.g., Xanax, Valium), muscle relaxants, or other sedatives creates a life-threatening risk of severe respiratory failure, coma, and death.
• Concomitant Acetaminophen Products: Avoid taking any other OTC or prescription products containing acetaminophen (e.g., NyQuil, Excedrin, Tylenol, Vicodin) to prevent accidental overdose.
• CYP3A4 and CYP2D6 Inhibitors/Inducers: Drugs that inhibit liver enzymes (e.g., erythromycin, ketoconazole, ritonavir) can increase oxycodone levels in the blood, leading to fatal overdose.
• Pre-existing Conditions:
• Respiratory Illnesses: Contraindicated in patients with severe bronchial asthma, hypercarbia, or upper airway obstruction.
• Head Injury & Intracranial Pressure: Opioids can elevate cerebrospinal fluid pressure and obscure the clinical course of head injuries.
• GI Obstruction: Contraindicated in patients with known or suspected paralytic ileus.

FDA Boxed Warnings

FDA BLACK BOX WARNINGS

• Addiction, Abuse, and Misuse: Oxycodone exposes users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death.
• Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur, especially during initiation or following a dosage increase.
• Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal overdose of oxycodone.
• Neonatal Opioid Withdrawal Syndrome (NOWS): Prolonged use during pregnancy can cause life-threatening withdrawal in the newborn child.
• Hepatotoxicity: Acetaminophen has been associated with cases of acute liver failure, sometimes resulting in liver transplant or death.
• Concomitant Use with Benzodiazepines or CNS Depressants: Co-prescription with benzodiazepines or other CNS depressants may result in profound sedation, respiratory depression, coma, and death.

• Pregnancy & Breastfeeding: Contraindicated during nursing, as oxycodone and acetaminophen pass into breast milk, posing a risk of severe sedation and respiratory depression in the infant.